E-LIB Suche - Ergebnisse für: Massacesi, Cristian

1

Diversity of US participants in AstraZeneca-sponsored clini..:

Cabrera, Claudia ; Fernández-Llaneza, Daniel ; Ghazoui, Zara...
Contemporary Clinical Trials. 140 (2024) - p. 107496 , 2024

Link: https://doi.org/10.1016/..

2

Implementation of digital health technology in clinical tri..:

Durán, Cristina Ortega ; Bonam, Matthew ; Björk, Elisabeth...
Nature Medicine. 29 (2023) 11 - p. 2693-2697 , 2023

Link: https://doi.org/10.1038/..

3

Addressing the Impact of the COVID-19 Pandemic on Survival ..:

Ye, Jiabu ; Yu, Binbing ; Mann, Helen...
Journal of Data Science. , 2022

Link: https://doi.org/10.6339/..

4

Curative-Intent Treatment with Durvalumab in Early-Stage Ca..:

Melillo, Giovanni ; Chand, Vikram ; Yovine, Alejandro..
Advances in Therapy. 38 (2021) 6 - p. 2759-2778 , 2021

Link: https://doi.org/10.1007/..

5

First-line ceritinib versus platinum-based chemotherapy in ..:

Soria, Jean-Charles ; Tan, Daniel S W ; Chiari, Rita...
The Lancet. 389 (2017) 10072 - p. 917-929 , 2017

Link: https://doi.org/10.1016/..

6

PI3K inhibitors as new cancer therapeutics: implications fo..:

Massacesi, Cristian ; Di Tomaso, Emmanuelle ; Urban, Patrick...
OncoTargets and Therapy. , 2016

Link: https://doi.org/10.2147/..

7

Phase I dose-escalation and -expansion study of buparlisib ..:

Rodon, Jordi ; Braña, Irene ; Siu, Lillian L...
Investigational New Drugs. 32 (2014) 4 - p. 670-681 , 2014

Link: https://doi.org/10.1007/..

8

Challenges in the clinical development of PI3K inhibitors:

Massacesi, Cristian ; di Tomaso, Emmanuelle ; Fretault, Nathalie.
Annals of the New York Academy of Sciences. 1280 (2013) 1 - p. 19-23 , 2013

Link: https://doi.org/10.1111/..

9

Phase I trial of oral mTOR inhibitor everolimus in combinat..:

Jerusalem, Guy ; Fasolo, Angelica ; Dieras, Veronique...
Breast Cancer Research and Treatment. 125 (2010) 2 - p. 447-455 , 2010

Link: https://doi.org/10.1007/..

10

First clinical experience of orally active epidermal growth..:

Zampino, Maria Giulia ; Magni, Elena ; Massacesi, Cristian...
Cancer. 110 (2007) 4 - p. 752-758 , 2007

Link: https://doi.org/10.1002/..

11

Sustained release octreotide may have a role in the treatme..:

Massacesi, Cristian ; Galeazzi, Giordano
Palliative Medicine. 20 (2006) 7 - p. 715-716 , 2006

Link: https://doi.org/10.1191/..

12

Uridine diphosphate glucuronosyl transferase 1A1 promoter p..:

Massacesi, Cristian ; Terrazzino, Salvatore ; Marcucci, Fabiana...
Cancer. 106 (2006) 5 - p. 1007-1016 , 2006

Link: https://doi.org/10.1002/..

13

Short Communication: The Efficacy of Fixed Dose Rate Infusi..:

Massacesi, Cristian ; Burattini, Luciano ; Marcucci, Fabiana.
Journal of Interferon & Cytokine Research. 25 (2005) 3 - p. 165-168 , 2005

Link: https://doi.org/10.1089/..

14

Raltitrexed plus Weekly Oxaliplatin as First-Line Chemother..:

Santini, Daniele ; Massacesi, Cristian ; D'Angelillo, Rolando Maria...
Medical Oncology. 21 (2004) 1 - p. 59-66 , 2004

Link: https://doi.org/10.1385/..

15

Randomized, multicenter, phase II study of gemcitabine plus..:

Mazzanti, Paola ; Massacesi, Cristian ; Rocchi, Marco B.L....
Lung Cancer. 41 (2003) 1 - p. 81-89 , 2003

Link: https://doi.org/10.1016/..